Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06564233 · ClinicalTrials.gov registry record · NA

Supportive Care Intervention for Outpatient Stem Cell Transplant Patients

A NA study of Cancer and Hematopoietic Stem Cell Transplantation, sponsored by Victor Wang.

Recruiting
Registry status
NA
Development phase
90
Enrollment target
1
Study location

NCT06564233 is a NA study of Cancer and Hematopoietic Stem Cell Transplantation that is actively recruiting participants, run by Victor Wang. The registered enrollment target is 90 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06564233, a NA study of Cancer and Hematopoietic Stem Cell Transplantation, is actively recruiting participants, sponsored by Victor Wang.

RECRUITING
Registry status
NA
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

The overall goal of this study is to assess the efficacy of the care.coach Avatar™ in improving anxiety and quality of life for patients undergoing outpatient transplant. After care.coach Avatar™ content and scheduling ("digital intervention" or "program") has been optimized for outpatient allogeneic hematopoietic stem cell transplantation (HCT), a randomized controlled trial (RCT) will be conducted of the digital versus usual supportive care program for outpatient HCT recipients. Potential improvements in anxiety and quality of life will be evaluated, with the intent of increasing comfortability with outpatient transplant and expanding the population of eligible patients willing to receive their transplants in an outpatient setting.

Interventions

  • BEHAVIORAL care.coach Avatar™

Study Locations (1)

Massachusetts

  • Dana-Farber Cancer Institute - Boston

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2024-10-21
Est. Completion 2026-11-29
Phase NA

Sponsor

Victor Wang

2 total trials

What the Registry Record Tells You About NCT06564233

The ClinicalTrials.gov registry entry for NCT06564233 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower). The listed sponsor is Victor Wang, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which care.coach Avatar™ is the first listed.

NCT06564233 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06564233 about?

NCT06564233 is a clinical study titled "Supportive Care Intervention for Outpatient Stem Cell Transplant Patients". The overall goal of this study is to assess the efficacy of the care.coach Avatar™ in improving anxiety and quality of life for patients undergoing outpatient transplant. After care.coach Avatar™ content and scheduling ("digital intervention" or "program") has been optimized for outpatient allogenei...

What is the current status of trial NCT06564233?

This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2024-10-21. Estimated completion is 2026-11-29.

What conditions does trial NCT06564233 study?

This clinical trial studies the following conditions: Cancer, Hematopoietic Stem Cell Transplantation.

What interventions are being tested in trial NCT06564233?

The interventions under investigation include: care.coach Avatar™ (BEHAVIORAL).

Who is sponsoring clinical trial NCT06564233?

This trial is sponsored by Victor Wang, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06564233 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.